GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharming Group (OTCPK:PHGUF) » Definitions » Other Operating Expense

PHGUF (Pharming Group) Other Operating Expense : $106.8 Mil (TTM As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is Pharming Group Other Operating Expense?

Pharming Group's Other Operating Expense for the three months ended in Sep. 2024 was $-0.8 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 was $106.8 Mil.

Pharming Group's quarterly Other Operating Expense declined from Mar. 2024 ($-0.3 Mil) to Jun. 2024 ($-0.9 Mil) but then increased from Jun. 2024 ($-0.9 Mil) to Sep. 2024 ($-0.8 Mil).

Pharming Group's annual Other Operating Expense increased from Dec. 2021 ($40.2 Mil) to Dec. 2022 ($56.8 Mil) and increased from Dec. 2022 ($56.8 Mil) to Dec. 2023 ($86.0 Mil).


Pharming Group Other Operating Expense Historical Data

The historical data trend for Pharming Group's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharming Group Other Operating Expense Chart

Pharming Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.55 8.86 40.23 56.82 85.98

Pharming Group Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.30 108.79 -0.34 -0.91 -0.78

Pharming Group Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $106.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharming Group Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Pharming Group's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharming Group Business Description

Traded in Other Exchanges
Address
Darwinweg 24, Leiden, ZH, NLD, 2333 CR
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.